Progresso na triagem de doadores de sangue para prevenir ITT no Japão

Program Date: 14 September 2022

Publication Date: 15 September 2022

Continuing Education Units: Hours: 1.0

Lecture Description:

Nesta palestra, Mashiro Satake apresentará o progresso para prevenir TTI na triagem de doadores de sangue com foco na implementação de ID-NAT e no uso de um sistema de triagem de combinação de Anti-HBc e Anti-HBs para prevenir HBV oculto relacionado a HBV-TTI.

Run Time: 48

Lecture Instructor Bio(s)

MASAHIRO SATAKE, PHD

Diretor-Geral, Instituto Hematológico da Cruz Vermelha do Japão e Diretor Executivo

Sede do Serviço Hematológico da Cruz Vermelha do Japão

O Dr. Satake fez seus Doutorado em Medicina e PHD da Escola de Medicina da Universidade de Tohoku, Japão. Ele completou a especialização em geral no Hospital Municipal de Yamagata. Antes de ingressar na Cruz Vermelha do Japão, ele atuou como cirurgião geral especializado em transplante de rins e fígado em vários hospitais.

Please click "Accept Sharing & Targeted Advertising" to enable full site functionality.

At this time, we are experiencing problems with broken links on our site. As an interim solution, for full site functionality you must enable functional and advertising cookies. If you continue to opt-out of these cookies, some content on our site may not be viewable.

We use functional cookies to analyze your use of the site, improve performance and provide a better customer experience. We use advertising cookies to allow us, through certain data assigned and obtained from the user's device, to store or share with third parties information related to user's browsing activity in our website, in order to create an advertising profile and place relevant advertising in our website or those third parties websites. For more information about how Abbott uses cookies please see our Cookie Policy and Privacy Policy.

In order to accept functional and advertising cookies, please click "Enable Cookies" and then click "Accept Sharing & Targeted Advertising" to view the full site.